Guosheng Furui led the Great Ran Gen Genzan Genzan RMB PRE-A round of financing

"Science and Technology Board Daily" on the 20th, Ranran Biomedical Technology (Shanghai) Co., Ltd. announced that it has completed tens of millions of RMB Pre-A round financing. This round of financing was led by Guosheng Furui, and Jinzhang Shanghui served as a financing consultant. The funds will be used to further promote the layout of the company's next -generation pathological technology (NGP) and the application for registration and registration of IVD products to accelerate the listing of products.

Company information shows that Ranran Gen is established in 2015. The company focuses on the research and application of precision medical transformation and is committed to providing one -stop molecular diagnosis solutions for multi -application scenarios. At present, Ran Ran Gene owns a dual R & D center, two medical inspection laboratories (including "zero defects" through CAP authoritative certification) and the Institute of Precision Medicine Science and Technology. Relying on the company's advantages, Ranran Gene continued to promote the establishment of precision medicine, industry alliances and industry standards, and pay attention to the development, registration, production and sales of molecular diagnostic reagents.

The business of Ranran Gene is mainly LDT business and IVD business. Among them, the LDT business includes a second -generation pathological technology NGP with a multi -dimensional assessment of the prognosis of tumor patients and the level of drug benefits; A physical tumors related to 565 genes related to 565 genes related to a variety of physical tumors such as tumor, pancreatic cancer, gastric cancer, and kidney cancer are targeted at tumor tumors of tumor tumor tumor that are originally visited by tissue, cerebral membrane, pituitary, cerebral nerve, and cerebral vascular tissue Essence The IVD business includes the central nervous system products suitable for early screening of central nervous system tumors; liver cancer products that are applicable to the full -cycle test of liver cancer and NGP kits that apply various types of cancer infection. It is reported that there are 6 IVD products registration reserves in Ranran Gene to serve more than 500 hospitals and scientific research institutions in China. The Geran Gene has established a huge genome database, adhering to the mission of "practicing precision medical care", and promoting the development of my country's medical care.

According to the data of smart buds, there are currently more than 30 patent applications from Ranran Gene and its related companies, of which more than 10 invention patents are invention. The company's patent layout is mainly focused on related fields such as kits, tumor genes, and diagnostic signs.

- END -